Taking these results together, it could be hypothesised that a defiency of MTUS1 could result in an increased activation of NF-κB and increased microvascular permeability, enabling the infiltration of inflammatory or metastatic cells and therefore an increased incidence of autoimmune disease and lymphoma. Here, NFKB1 is linked to autoimmune disease.